Ardelyx is categorized under Commercial Biotechnical Research in Fremont, CA and active since 2007.
Ardelyx was established in 2007, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Mike Raab, Chief Executive Officer at the company’s single location by writing to 34175 Ardenwood Boulevard, Fremont, California CA 94555 or by phoning (510) 745-1700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ardelyx |
Contact Person: | Mike Raab, Chief Executive Officer |
Address: | 34175 Ardenwood Boulevard, Fremont, California 94555 |
Phone Number: | (510) 745-1700 |
Website Address: | ardelyx.com |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 3254120 |
Share This Business: |
Ardelyx was started in 2007 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Mike Raab, Chief Executive Officer for inquiries that concern Ardelyx by calling the company number (510) 745-1700, as your correspondence is most welcome. Additionally, the physical location of the single location of Ardelyx can be found at the coordinates 37.564744,-122.0668 as well as the street address 34175 Ardenwood Boulevard in Fremont, California 94555.
For its online presence, you may visit Ardelyx’s website at ardelyx.com and engage with its social media outlets through on Twitter and on Facebook.